Business Description
Definitive Healthcare Corp
NAICS : 923120
SIC : 7372
ISIN : US24477E1038
Share Class Description:
DH: Class ATotal Employee Number:
686Description
Definitive Healthcare Corp is a provider of healthcare commercial intelligence. Its SaaS-based healthcare commercial intelligence platform is designed to provide comprehensive and accurate information on the healthcare ecosystem in the U.S. The platform uses deep analytics and data science to help customers develop data-driven strategic decisions, such as finding new markets to enter, building comprehensive go-to-market strategies, accessing tactical information to help target the right decision makers, and improving win rates with detailed contextual information. The company derives substantially all of its revenue from the sale of subscription fees for access to its platform and stand-ready support. Geographically, it derives a majority of its revenue from the United States.
Financial Strength
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 1.05 | |||||
Equity-to-Asset | 0.28 | |||||
Debt-to-Equity | 1.16 | |||||
Debt-to-EBITDA | -0.99 | |||||
Piotroski F-Score | 5/9 | |||||
Altman Z-Score | -3.1 | |||||
Beneish M-Score | -2.76 | |||||
WACC vs ROIC | ||||||
Growth Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 0.9 | |||||
3-Year EPS without NRI Growth Rate | 1.4 | |||||
3-Year FCF Growth Rate | 8.7 | |||||
3-Year Book Growth Rate | -33.1 |
Momentum Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 34.08 | |||||
9-Day RSI | 34.7 | |||||
14-Day RSI | 37.32 | |||||
3-1 Month Momentum % | -23.23 | |||||
6-1 Month Momentum % | -67.47 | |||||
12-1 Month Momentum % | -78.7 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 1.75 | |||||
Quick Ratio | 1.75 | |||||
Cash Ratio | 1.27 | |||||
Days Sales Outstanding | 64.58 | |||||
Days Payable | 43.87 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | 0.4 | |||||
Shareholder Yield % | 118.33 |
Profitability Rank
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 76.04 | |||||
Operating Margin % | -7.74 | |||||
Net Margin % | -71.49 | |||||
EBITDA Margin % | -72.21 | |||||
FCF Margin % | 11.36 | |||||
OCF Margin % | 16.48 | |||||
ROE % | -63.62 | |||||
ROA % | -23.76 | |||||
ROIC % | -3.15 | |||||
3-Year ROIIC % | -0.1 | |||||
ROC (Joel Greenblatt) % | -1291.08 | |||||
ROCE % | -40.26 | |||||
Moat Score | 4 | |||||
Tariff Resilience Score | 9 |
GF Value Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Forward PE Ratio | 4.11 | |||||
PE Ratio without NRI | 1.05 | |||||
PS Ratio | 0.32 | |||||
PB Ratio | 0.55 | |||||
Price-to-Free-Cash-Flow | 2.95 | |||||
Price-to-Operating-Cash-Flow | 2 | |||||
EV-to-EBIT | -0.51 | |||||
EV-to-Forward-EBIT | 19.53 | |||||
EV-to-EBITDA | -0.68 | |||||
EV-to-Forward-EBITDA | 18.04 | |||||
EV-to-Revenue | 0.49 | |||||
EV-to-Forward-Revenue | 0.31 | |||||
EV-to-FCF | 4.3 | |||||
Price-to-GF-Value | 0.17 | |||||
Earnings Yield (Greenblatt) % | -196.08 | |||||
FCF Yield % | 33.74 |
Definitive Healthcare Corp Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Definitive Healthcare Corp Stock Events
| Event | Date | Price ($) | ||
|---|---|---|---|---|
| Third quarter earnings conference call for 2026 | 2026-11-06 17:00 | In 135 days | ||
| Third quarter earnings results for 2026 | 2026-11-06 | In 134 days | ||
| Second quarter earnings conference call for 2026 | 2026-08-07 17:00 | In 44 days | ||
| Second quarter earnings results for 2026 | 2026-08-07 | In 43 days | ||
| General meeting for 2026 | 2026-06-04 14:00 | 0.88 (-7.68%) | ||
| First quarter earnings conference call for 2026 | 2026-05-07 17:00 | 0.95 (-2.07%) | ||
| First quarter earnings results for 2026 | 2026-05-07 | 0.95 (-2.07%) | ||
| Fourth quarter earnings conference call for 2025 | 2026-02-26 17:00 | 1.41 (+1.44%) | ||
| Annual report for 2025 | 2026-02-26 | 1.41 (+1.44%) | ||
| Fourth quarter earnings results for 2025 | 2026-02-26 | 1.41 (+1.44%) |
Show
Entries
Guru Commentaries on NAS:DH
No articles.
Press Release
Articles on Definitive Healthcare Corp
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers